Amalgamated Financial’s Bioventus BVS Stock Holding History

Amalgamated Financial’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$60K	Buy	+4,253	New	+$56.9K	﹤0.01%	2330

Other funds holding BVS

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Amalgamated Financial's BVS Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Bioventus (BVS) in Q1 2022: 4,253 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #2330 among its holdings.

105 funds tracked by Wall St. Rank hold BVS as of Q1 2022.

Amalgamated Financial held 4,253 shares of Bioventus worth $60K as of Q1 2022.
Bioventus was a new Amalgamated Financial position in Q1 2022.
Bioventus made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2330 holding.
105 funds tracked by Wall St. Rank held Bioventus as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.